On February 28, 2026, the United States and Israel launched Operation Epic Fury against Iran, targeting leadership compounds and missile infrastructure. By March 1, Tehran confirmed the death of Ayatollah Ali Khamenei. Retaliatory strikes followed against U.S. bases in Bahrain and Qatar, widening the …
AeroVironment Inc (NASDAQ:AVAV) closed at$208.32, down17.42% (-$43.93). The decline follows a period of strong performance in defense and aerospace equities.
AES Corporation (NYSE:AES) declined17.77%, closing at$14.21 on 2 March 2026. Unlike micro-cap volatility, AES represents a larger-cap utility name, making the magnitude of the drop more significant from an institutional standpoint.
PureCycle Technologies Inc (NASDAQ:PCTTW) closed at$0.35, declining31.37% (-$0.16). The steep drop underscores persistent volatility within small-cap clean technology names.
UniQure NV (NASDAQ:QURE) closed at$10.50, plunging32.82% (-$5.13)in a single session. The magnitude of the decline places QURE among the sharpest biotech decliners of the day and reflects heightened volatility across development-stage pharmaceutical names.
Innoviz Technologies Ltd (NASDAQ:INVZW) closed at$0.007, tumbling33.33% (-$0.003)and ranking among the sharpest decliners in US markets. The percentage drop appears dramatic, but the move reflects the inherent volatility of ultra-low-priced securities where even minor nominal changes translate into outsized percentage swings.
Sabre Corporation (NASDAQ:SABR) closed at$1.60, soaring36.02% (+$0.42)on March 2, 2026, making it one of the top US-listed gainers. The sharp rally followed steady price stabilization throughout February before buyers stepped in aggressively during the latest session.
Astra Health Inc. (NASDAQ:ASTH) surged29.46%to close at$26.32on March 2, 2026. The $5.32 gain reflects renewed investor appetite for healthcare and biotech growth stocks.
Applied Optoelectronics Inc. (NASDAQ:AAOI) surged21.70%to close at$102.51, gaining $18.28. The move decisively pushed the stock above the key $100 psychological barrier.
Ocular Therapeutix (NASDAQ:OCUL) rose22.98%to close at$10.98 on March 02, 2026. The move followed steady accumulation during February before a breakout session.